Title: Experiences on ongoing cancer immunotherapy with Nivolumab Pembrolizumab and Ipilimumab: Insights from patients and oncology healthcare professionals in South Wales UK

Funder
Macmillan Cancer Support

Principal Investigator

Project Details
Net value award figure for Cardiff University: £108,402.00
Start date: 01/12/2019
End date: 31/05/2021

Last updated on 2020-13-08 at 06:02